VITROS 3600 IMMUNODIAGN SYSTEM
Total Payments
$1.2M
Transactions
48
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $1.2M | 48 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 48 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Specimen Collection Protocol | Ortho-Clinical Diagnostics, Inc. | $438,287 | 0 |
| VITROS Immunodiagnostics Products Syphilis Assay Intended Use Sample Collection | Ortho-Clinical Diagnostics, Inc. | $181,643 | 0 |
| Qualification of Vaccine/infection boosted donor plasma for high titer CCP based on Demonstration of Neutralization against SARS-CoV-2 Variants and Correlation with VITROS IgG Quantitative Antibody Titers | Ortho-Clinical Diagnostics, Inc. | $169,617 | 0 |
| VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Clinical Testing Protocol for 510(k) | Ortho-Clinical Diagnostics, Inc. | $125,014 | 0 |
| VITROS Immunodiagnostic Products B?R?A?H?M?S PCT Test Fresh Sample Collection and Testing | Ortho-Clinical Diagnostics, Inc. | $118,258 | 0 |
| Effective Triage of Patients Presenting with COVID-19 | Ortho-Clinical Diagnostics, Inc. | $63,651 | 0 |
| VITROS Immunodiagnostic Product SARS-CoV-2 Antigen Specimen Collection Protocol | Ortho-Clinical Diagnostics, Inc. | $59,102 | 0 |
| VITROS Anti-SARS-CoV-2 Total and VITROS Anti-SARS-CoV-2 IgG | Ortho-Clinical Diagnostics, Inc. | $18,772 | 0 |
| VITROS Immunodiagnostic Products Total PSA III Aid in Management Intended Use Sample Collection | Ortho-Clinical Diagnostics, Inc. | $18,063 | 0 |
| iPTH Fresh Sample Collection | Ortho-Clinical Diagnostics, Inc. | $3,897 | 0 |
| VITROS PHBR Slides Fresh Sample Collection Protocol | Ortho-Clinical Diagnostics, Inc. | $1,833 | 0 |
| VITROS Immunodiagnostic Products hs Troponin I US Sample Collection Protocol | Ortho-Clinical Diagnostics, Inc. | $1,500 | 0 |
Top Doctors Receiving Payments for VITROS 3600 IMMUNODIAGN SYSTEM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Leesburg, VA | $1.2M | 48 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $1.2M
- Total Doctors 0
- Transactions 48
About VITROS 3600 IMMUNODIAGN SYSTEM
VITROS 3600 IMMUNODIAGN SYSTEM is a device associated with $1.2M in payments to 0 healthcare providers, recorded across 48 transactions in the CMS Open Payments database. The primary manufacturer is Ortho-Clinical Diagnostics, Inc..
Payment data is available from 2022 to 2022. In 2022, $1.2M was paid across 48 transactions to 0 doctors.
The most common payment nature for VITROS 3600 IMMUNODIAGN SYSTEM is "Unspecified" ($1.2M, 100.0% of total).
VITROS 3600 IMMUNODIAGN SYSTEM is associated with 12 research studies, including "VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Specimen Collection Protocol" ($438,287).